← Evidence map

ReviewDrugs2022

Nirmatrelvir Plus Ritonavir: First Approval.

Yvette N LambPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

157 papers cite itlatest 60 shown

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

NCT05749445200 enrolled2022
Full record →Abstract, authors, funding and every citing paper · PMID 35305258